Login / Signup

Minimizing the risk of Clostridioides difficile infection as an early complication of autologous stem cell transplantation.

Joseph Van GalenSamuel D MaldonadoKyle GroseFrancis BagleyRachele OlivierJenna Van HooseMichael KengLeonid Volodin
Published in: Antimicrobial stewardship & healthcare epidemiology : ASHE (2023)
This quality improvement project aimed to reduce institutional incidence of Clostridioides difficile infection (CDI) following autologous stem cell transplantation. CDI incidence per transplant was .17 in a baseline period and .09 following the implementation of postdischarge ultraviolet room cleaning (χ 2 = 2.11, p  = .15).
Keyphrases
  • stem cell transplantation
  • quality improvement
  • clostridium difficile
  • high dose
  • patient safety
  • risk factors
  • bone marrow
  • cell therapy
  • platelet rich plasma
  • primary care
  • low dose
  • stem cells
  • mesenchymal stem cells